Inhibition of lipolysis does not affect insulin sensitivity to glucose uptake in the mourning dove.
Birds have much higher plasma glucose and fatty acid levels compared to mammals. In addition, they are resistant to insulin-induced decreases in blood glucose. Recent studies have demonstrated that decreasing fatty acid utilization alleviates insulin resistance in mammals, thereby decreasing plasma glucose levels. This has yet to be examined in birds. In the present study, the levels of glucose and beta-hydroxybutyrate (BOHB), a major ketone body and indicator of fatty acid utilization, were measured after the administration of chicken insulin, acipimox (an anti-lipolytic agent), or insulin and acipimox in mourning doves (Zenaidura macroura). Insulin significantly decreased whole blood glucose levels (19%), but had no effect on BOHB concentrations. In contrast, acipimox decreased blood BOHB levels by 41%, but had no effect on whole blood glucose. In addition to changes in blood composition, levels of glucose uptake by various tissues were measured after the individual and combined administration of insulin and acipimox. Under basal conditions, the uptake of glucose appeared to be greatest in the kidney followed by the brain and skeletal muscle with negligible uptake by heart, liver and adipose tissues. Acipimox significantly decreased glucose uptake by brain (58% in cortex and 55% in cerebellum). No significant effect of acipimox was observed in other tissues. In summary, the acute inhibition of lipolysis had no effect on glucose uptake in the presence or absence of insulin. This suggests that free fatty acids alone may not be contributing to insulin resistance in birds.
Sweazea
Karen L
KL
Department of Physiology, Arizona Health Sciences Center, P.O. Box 245051, University of Arizona, Tucson, 85724-5051, USA.
McMurtry
John P
JP
Braun
Eldon J
EJ
D020155:3-Hydroxybutyric Acid / Q000097:blood; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D010856:Columbidae / Q000097:blood / Q000378:metabolism*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007333:Insulin Resistance; D008066:Lipolysis / Q000187:drug effects / Q000502:physiology*; D008297:Male; D011719:Pyrazines / Q000494:pharmacology*; D014018:Tissue Distribution / Q000187:drug effects
D001786:Blood Glucose; D005227:Fatty Acids; D007328:Insulin; D011719:Pyrazines; C027696:acipimox; D020155:3-Hydroxybutyric Acid